Security key
74907L409
Quoin Pharmaceuticals, Ltd. - Ordinary Shares, no par value per share (QNRX)
CUSIP: 74907L409
Q1 2025 13F Holders as of 31 Mar 2025
- Security type / class
- Equity / Ordinary Shares, no par value per share
- Total 13F shares
- 108
- Total 13F value
- $24
- Share change
- +108
- SEC-reported price per share
- $0.22
- Number of holders
- 1
- Value change
- +$24
- Number of buys
- 1
- Shares outstanding
- 70,007,000
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2025
Institutions
1
Top holders
1
QNRX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2025
Quoin Pharmaceuticals, Ltd. SEC filings
Quoin Pharmaceuticals, Ltd. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 74907L409
Recent filing periods:
Ownership snapshot
Top reported holders of QNRX - Quoin Pharmaceuticals, Ltd. - Ordinary Shares, no par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ARMISTICE CAPITAL, LLC
Disclosed value leader
ARMISTICE CAPITAL, LLC
Comparable rows
15/15
Latest evidence
31 Mar 2025
13D/G
13F
Lead comparable stake: 5%
13D/G row: ARMISTICE CAPITAL, LLC
Showing 1-6 of 15 holder rows.
Quick read
ARMISTICE CAPITAL, LLC leads the comparable SEC ownership view at 5%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ARMISTICE CAPITAL, LLC's linked filing trail.
Comparable ownership
Top 5
ARMISTICE CAPITAL, LLC
5%
Denise P. Carter
4.9%
Michael Myers
4.9%
Altium Capital Management LLC
3%
Ikarian Capital, LLC
2.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13D/G
13F
Company
|
5%
|
$7,049,313
1,081,183 shares
|
$0 | 31 Mar 2025 |
| Denise P. Carter |
13D/G
Denise Carter
|
4.9%
|
$244,202
939,238 shares
|
+$82,374 | 27 Jan 2025 |
| Michael Myers |
13D/G
|
4.9%
|
$244,200
939,230 shares
|
+$82,331 | 27 Jan 2025 |
| Altium Capital Management LLC |
13F
Company
|
3%
|
$183,659
282,249 shares
|
— | 31 Dec 2024 |
| Ikarian Capital, LLC |
13F
Company
|
2.9%
|
$178,942
275,000 shares
|
— | 31 Dec 2024 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
1.4%
|
$86,622
133,122 shares
|
— | 31 Dec 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
108
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2025 vs Q1 2026 Across Filers
Q1 2026 holders
20
Q1 2025 holders
1
Holder diff
-19
| Investor | Q1 2026 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q1 2026 value | Q1 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend